Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses

34Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

Abstract

According to the cancer stem cell (CSC) theory, therapies that do not target the CSC compartment have limited, if any, chances to eradicate established tumors. While cytotoxic T lymphocytes (CTLs) have the potential to recognize and kill single neoplastic cells within a tissue, whether CSC s can be targeted by the immune system during spontaneous or vaccination-elicited responses is poorly defined. Here, we provide experimental evidence showing that CSC lines established from the prostate of transgenic adenocarcinoma of the mouse prostate (TRAMP) mice expressed prostate cancer-associated antigens, MHC Class I and II molecules as well as ligands for natural killer (NK) cell receptors. Indeed, CSC were targets for both NK cell- and CTL-mediated cytotoxicity, both in vitro and in vivo. The administration of dendritic cells pulsed with irradiated CSC s induced a tumor-specific immune response that was more robust than that induced by dendritic cells pulsed with differentiated tumor cells, delayed tumor growth in mice challenged with prostate CSC s and caused tumor regression in TRAMP mice. Thus, CSC are targeted by both innate and adaptive immune responses and might be exploited for the design of novel immunotherapeutic approaches against cancer. © 2013 Landes Bioscience.

References Powered by Scopus

Cancer statistics, 2012

10669Citations
N/AReaders
Get full text

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

5283Citations
N/AReaders
Get full text

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

4728Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cancer stem cells: Regulation programs, immunological properties and immunotherapy

107Citations
N/AReaders
Get full text

Tenascin-C protects cancer stem-like cells from immune surveillance by arresting T-cell activation

107Citations
N/AReaders
Get full text

Concise Review: Prostate Cancer Stem Cells: Current Understanding

97Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Jachetti, E., Mazzoleni, S., Grioni, M., Ricupito, A., Brambillasca, C., Generoso, L., … Bellone, M. (2013). Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses. OncoImmunology, 2(5). https://doi.org/10.4161/onci.24520

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

58%

Researcher 11

33%

Professor / Associate Prof. 3

9%

Readers' Discipline

Tooltip

Immunology and Microbiology 12

34%

Agricultural and Biological Sciences 9

26%

Medicine and Dentistry 8

23%

Biochemistry, Genetics and Molecular Bi... 6

17%

Save time finding and organizing research with Mendeley

Sign up for free